Cell-specific delivery of genes with glycosylated carriers

Advanced Drug Delivery Reviews

Volumn 52, Issue 3, 2001, Pages 187-196

  Hashida, Mitsuru ^a   Nishikawa, Makiya ^a   Yamashita, Fumiyoshi ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Galactosylated liposomes; Galactosylated polymers; Gene therapy; Hepatocyte specific delivery; Mannosylated carriers; Plasmid DNA delivery

Indexed keywords

CELLS; GENES; IMMUNOLOGY; POLYMERS; VIRUSES;

GENE DELIVERY;

CONTROLLED DRUG DELIVERY;

ASIALOGLYCOPROTEIN RECEPTOR; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MANNOSE; PLASMID DNA; POLYAMINOACID; POLYMER;

CELL SPECIFICITY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GLYCOSYLATION; IN VITRO STUDY; IN VIVO STUDY; LIVER PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CELLS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; TRANSFECTION;

EID: 0035915017     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00209-5     Document Type: Review

References (61)

1. Nonviral vectors for in vivo gene delivery: Physicochemical and pharmacokinetic considerations
2. Non-viral peptide-based approaches to gene delivery
3. Systemic gene expression after intravenous DNA delivery into adult mice
4. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes
5. Physicochemical and pharmacokinetic characterization of plasmid DNA/cationic liposome complexes
6. Liposomal gene delivery: A complex package
7. Receptor-mediated gene delivery and expression in vivo
8. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes
9. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses
10. Pharmacokinetics and targeted delivery of proteins and genes
11. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)
12. Receptor-mediated gene transfer into macrophages
13. Gene transfer by DNA/glycosylated polylysine complexed into human blood monocyte-derived macrophages
14. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
15. Enhanced gene transfection in macrophages using mannosylated cationic liposomes-polyethyleneimine-plasmid DNA complexes
16. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice
17. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier
18. Transferrin-polycation-DNA complexes: The efficient of polycations on the structures of complex and DNA delivery to the cells
19. Coupling of cell-binding ligands to polyethyleneimine for targeted gene delivery
20. A novel gene delivery system using EGF receptor-mediated endocytosis
21. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor
22. Application of membrane-active peptides for nonviral gene delivery
23. Control of pharmacokinetic profiles of drug-macromolecule conjugates
24. Pharmacokinetics of anticancer drugs, plasmid DNA and their delivery systems in tissue-isolated purfuse tumors
25. Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution
26. 1 polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice
27. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion
28. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties
29. Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives
30. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine)
31. Asialoglycoprotein receptor-mediated gene transfer using novol galactopsylated cationic liposomes
32. In vivo gene delivery to the liver using novel galastosylated cationic liposomes
33. Development of gene drug delivery systems based on pharmacokinetic studies
34. The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated catrionic liposomes in mice
35. The fate of plasmid DNA after intravenous injection in mice: Involvment of scavenger receptors in its hepatic uptake
36. Involvment of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages
37. Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice
38. Cationic liposome-mediated intravenous gene delivery
39. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
40. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes
41. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
42. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
43. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity
44. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
45. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular and trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression
46. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration
47. Lipoplex-mediated gene delivery to the lung occurs within 60 min of intravenous administration
48. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: The role of neutral helper lipid
49. Extravasation of macromolecules
50. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes
51. Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor
52. Liposomal sustained-release delivery systems for intravenous injection II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes
53. Pharmacokinetic evaluation of polymeric carriers
54. 1 for cell-specific hepatic targeting
55. Pharmacokinetic analysis of uptake process of lactosaminated albumin in rat liver constant infusion experiments
56. Carbohydrate-specific receptors of the liver
57. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
58. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector
59. Gene therapy for HIV-1 infection
60. Transfection of adherent murine peritoneal macrophages with a reporter gene using DEAE-dextran
61. A novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages